Multiple interconnected pathways may underlie impaired brain insulin signaling in schizophrenia. These include both central/neurobiological mechanisms (i.e., neuroinflammation, mitochondrial dysfunction, Akt pathway dysfunction, oxidative stress) and peripheral mechanisms (i.e., visceral adiposity, increased insulin release, chronic stress, and inflammation). Additionally, antipsychotic medications exacerbate both peripheral and central mechanisms, contributing to increased appetite and weight gain, increased insulin release, increased hepatic glucose production, and decreased glucose uptake by skeletal muscle.
Related content
Schizophrenia is associated with interacting genetic, environmental, and neurobiological factors that affect brain development, neurotransmission, immune function, and neural circuits.
In this video, Professor Dr. Ana Catalan explores whether psychotic disorders can be prevented and reviews the latest evidence on early intervention in psychosis. She explains how personalized, evidence-based care can enhance quality of life, daily functioning, and long-term recovery for people at risk of or experiencing psychosis.
Schizophrenia is associated with substantial disability, reduced life expectancy, and increased rates of psychiatric and physical comorbidities.